{{Rsnum
|rsid=80338851
|Chromosome=13
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=B3GALTL
|position=31269278
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=B3GALTL
}}{{omim
|id=610308
|rsnum=80338851
|variant=0001
}}{{ClinVar
|rsid=80338851
|Reversed=0
|FwdREF=G
|FwdALT=A
|REF=G
|ALT=A
|RSPOS=31843415
|CHROM=13
|dbSNPBuildID=131
|SSR=0
|SAO=1
|VP=0x050168000000040002110100
|GENEINFO=B3GALTL:145173
|GENE_NAME=B3GALTL
|GENE_ID=145173
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000013.10:g.31843415G>A
|CLNSRC=GeneReviews; OMIM Allelic Variant
|CLNORIGIN=0
|CLNSRCID=NBK1464; 610308.0001
|CLNSIG=5
|CLNCUI=C0796012; C0796012
|CLNDBN=Peters plus syndrome; not provided
|Disease=Peters plus syndrome; not provided
|CLNACC=RCV000001326.1; RCV000082789.1
|Tags=PM;PMC;SLO;VLD;OTHERKG;LSD;OM
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet
|CLNDSDBID=NBK1464:C0796012:261540:709
}}{{PMID Auto
|PMID=16909395
|Title=Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase.
|OA=1
}}

{{PMID Auto
|PMID=18199743
|Title=Peters Plus syndrome is a new congenital disorder of glycosylation and involves defective Omicron-glycosylation of thrombospondin type 1 repeats.
}}{{PMID Auto
|PMID=23213277
|Title=Absence of NR2E1 mutations in patients with aniridia.
|OA=1
}}